Allied Market Research

2024

Farm Animal External Medicine Market

Farm Animal External Medicine Market Size, Share, Competitive Landscape and Trend Analysis Report by Livestock, by Animal Type, by Product Type, by Route of Administration and by Sales Channel : Opportunity Analysis and Industry Forecast, 2023-2032

LS : Other

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

The report provides in-depth analysis of the market, outlining current trends, driving factors, restraints, and key areas of investment. The report features the strategies adopted by key market players to maintain their foothold in the market. Furthermore, it highlights the competitive landscape of the key players to increase their market share and sustain intense competition in the industry.

Segmental Analysis

The Farm animal external medicine market is segmented into by livestock, by animal type, by product type, by route of administration, by sales channel as well as comprises the market estimations depending on regional and country level analysis.

Competitive Analysis

The company profile section of the report covers strategic developments, business overview, product offerings, and financial performance of the companies. It also highlights the strategies adopted by companies such as products launch, agreements, partnerships, acquisitions mergers, collaborations, joint ventures, research & development investment, and regional expansion in the past few years.

Key companies identified in the report include Bayer AG, Ceva Sante Animale, Vetoquinol SA, Zoetis, Inc., Merck and Co., Inc., Elanco, An Eli Lilly Company, Boehringer Ingelheim International GmbH, Virbac SA, Virbac SA, Nutreco N.V.

Additional Customization Offered

  • Criss Cross/3rd level segmentation

  • Additional company profiles

  • Inclusion of new segmentations

  • Market strategies adopted by key players to sustain competition in the market

The Report Caters Below Key Points

  • The potential business segment

  • The highest revenue contributors

  • The estimated market demand at regional and country level

  • Top players and their detailed analysis

  • Industry and value chain analysis

Key Reasons to Buy the Report

  • Detailed country level segment analysis

  • Key supplier profiling and market share analysis

  • Major regions/country level quantitative and qualitative analysis

  • Free 20% customization and post-sales support

Farm Animal External Medicine Market Report Highlights

Aspects Details
icon_5
By Livestock
  • Cattle
  • Sheep
  • Goats
  • Pigs
  • Poultry
icon_6
By Animal Type
  • Ruminants
  • Non-Ruminants
  • Avian Animals
icon_7
By Product Type
  • Vaccines
  • Anti-Infectives
  • Parasiticides
  • Diagnostics
  • Vitamins
  • Others
icon_8
By Route of Administration
  • Intramuscular
  • Oral
  • Intravenous
  • Subcutaneous
icon_9
By Sales Channel
  • Distributors
  • Direct to Customer
  • Retail
icon_10
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_11
Key Market Players

Boehringer Ingelheim International GmbH, An Eli Lilly Company, Vetoquinol SA, Bayer AG, Zoetis, Merck and Co., Nutreco N.V., Virbac SA, Virbac SA, Ceva Sante Animale, Elanco

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Farm Animal External Medicine Market

Opportunity Analysis and Industry Forecast, 2023-2032